Taro pharmaceutical industries ltd (TARO)
CashFlow / Yearly
Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Dec'11Dec'10Dec'09
Cash flows from operating activities:
Net income

210,079

456,666

541,271

484,834

360,859

266,870

183,278

64,551

116,751

Adjustments required to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

16,496

14,829

14,848

15,798

16,567

17,765

18,730

18,827

18,445

Change in deferred charges and other assets

-

-

-

-

10

26

30

42

69

Impairment of long-lived assets

0

276

2,042

90

47

969

784

2,730

3,534

Share-based compensation expense

-

-

-

-

-

8

59

285

307

Accrued severance pay and other long-term liabilities, net

-227

273

-53

54

-230

55

-786

-122

-

Realized loss (gain) on sale of marketable securities and long-lived assets

-275

8,389

-74

-

-

-

-

-

-

Change in derivative instruments, net

893

-1,434

6,137

-5,483

-4,181

-1,550

-5,239

2,140

4,019

Effect of exchange differences on intercompany balances

-9,467

6,017

2,268

18,167

11,670

1,510

3,249

-307

8,713

Foreign exchange effect of marketable securities and bank deposits

-25,503

15,157

5,510

-

-

-

-

-

-

Decrease in long-term debt due to currency fluctuations

-

-

-

-1,030

1,137

440

-1,835

3,362

2,401

Deferred income taxes, net

-56,007

-73,706

11,976

70,387

23,708

-18,822

-21,374

6,720

-78,191

(Increase) decrease in trade receivables, net

2,297

-34,413

16,386

85,277

19,755

8,912

47,565

11,519

-1,081

Decrease (increase) in other receivables, prepaid expenses and other

-2,020

4,829

3,518

3,506

1,557

1,339

622

-3,251

-3,229

Increase in inventories, net

1,978

3,770

19,013

7,027

10,697

630

24,464

14,464

-762

Decrease (increase) in other long-term assets

-

-

-

-242

-64

-

-

-

-

Decrease in long-term receivables, prepaid expenses and other

-

-

-

-

-

-301

-196

-2,544

842

Decrease (increase) in income tax receivables

-10,624

70,390

39,340

-17,623

17,930

-

-291

18

1

Increase (decrease) in trade payables

9,049

-2,290

-679

-542

1,804

-3,483

1,664

-6,367

690

Decrease in other accounts payable and accrued expenses

-11,785

-28,377

-6,194

18,731

50,686

43,500

26,603

5,605

-5,824

Increase (decrease) in income tax payables

2,027

-4,843

-52,033

50,078

7,815

-48,094

43,857

-3,143

-2,681

(Gain) loss on sale of long-lived assets

-

-

-

-22

-

-

-

-

-

Loss on sale of long-lived assets

-

-

-

-

-44

-13

-526

-65

-34

Accrued severance pay and other long-term liabilities, net

-

-

-

-

-

-

-

-

539

Income from marketable securities, net

678

-

-

231

23

57

-45

32

-

Net cash provided by operating activities

323,689

437,535

395,128

406,788

357,644

248,650

181,407

70,484

63,919

Cash flows from investing activities:
Purchase of property, plant and equipment

26,886

35,755

18,972

19,997

21,249

9,466

6,293

5,656

5,025

Investment in other intangible assets

2,650

68

134

158

4,555

777

-

5,097

-

Proceeds from other assets

-

-10

-35,000

31,050

-

-

-

-

-

Proceeds from (investment in) short-term bank deposits, net

-161,032

-196,170

220,102

43,344

120,648

241,671

60,033

10,026

10,974

Proceeds from restricted bank deposits

-

-

199

28

7,203

8,224

-15,562

900

-

Proceeds from (investment in) long-term deposits and other assets

-396,281

286,617

80,587

-2,112

33,956

5,000

-74

310

-

Investment in marketable securities

1,140,853

376

170

-

-

-

-

-

-

(Investment in) proceeds from marketable securities, net

-

-

-

111

-100

4,758

1,053

-3,891

-

Investment in other intangible assets

-

-

-

-

-

-

-

-

120

Proceeds from restricted bank deposits

-

-

-

-

-

-

-

-

-1,000

Proceeds from long-term deposits and other assets

-

-

-

-

-

-

-

-

-14

Proceeds from marketable securities

370,363

350

35

-

-

-

-

-

-

Proceeds from sale of long-lived assets

1,075

8,508

-

217

8

1

431

69

1,655

Net cash used in investing activities

-241,638

-117,778

-284,731

-92,081

-173,297

-243,931

-80,330

-24,011

-13,450

Cash flows from financing activities:
Excess tax benefits from share-based payment arrangements

-

-

-

-

149

838

-

-

-

Proceeds from issuance of shares, net

-

-

-

26

1,262

6,584

8,850

21,775

163

Repurchase of treasury stock

106,986

294,897

9,450

-

192,999

-

-

-

-

Repayment of short-term bank debt, net

-

-

-

-

-

-

-

-73,331

1,660

Proceeds from long-term debt and capital leases

-

-

-

-

-

-

-

22

-

Proceeds from long-term debt

-

-

5,888

10,944

11,874

10,748

12,898

34,579

30,403

Net cash used in financing activities

-106,986

-294,897

-15,338

-10,918

-203,462

-3,326

-4,048

-86,113

-28,580

Effect of exchange rate changes on cash and cash equivalents

1,147

-1,218

57

-32,115

-8,202

-2,375

-1,172

477

2,590

(Decrease) increase in cash and cash equivalents

-23,788

23,642

95,116

271,674

-27,317

-982

95,857

-39,163

24,479

Supplemental disclosure of cash flow transactions:
Cash paid during the year for:
Interest

-

-

85

1,014

1,695

2,230

3,447

6,171

8,256

Income taxes

55,051

99,720

192,964

101,651

117,409

133,612

5,102

9,454

11,970

Cash received during the year for:
Income taxes

36,668

1,938

-

-

-

-

-

-

-

Non-cash investing transactions:
Purchase of property, plant and equipment included in accounts payable

2,281

692

1,744

645

1,714

1,573

790

397

755

Non-cash financing transactions:
Purchase of treasury stock

4,348

-

-

-

-

-

-

-

-

Purchase of Marketable Securities

3,491

-

-

-

-

-

-

-

-